Argyle Capital Management Inc. - Q4 2021 holdings

$320 Million is the total value of Argyle Capital Management Inc.'s 129 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .

 Value Shares↓ Weighting
MDT NewMedtronic Inc$4,500,00043,500
+100.0%
1.40%
DUK NewDuke Energy Corp$4,414,00042,078
+100.0%
1.38%
TRP NewTC Energy Corp$1,040,00022,350
+100.0%
0.32%
VMW NewVMware Inc$654,0005,648
+100.0%
0.20%
DLX NewDeluxe Corp$209,0006,500
+100.0%
0.06%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-01-25
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Microsoft Corp42Q3 20235.3%
Merck & Co Inc42Q3 20233.2%
Pfizer Inc42Q3 20232.8%
Amgen Inc42Q3 20232.9%
Intel Corp42Q3 20233.1%
Bristol Myers Squibb Co42Q3 20232.9%
Paychex Inc42Q3 20232.3%
Lilly Eli Co42Q3 20234.4%
Verizon Communications42Q3 20232.6%
Johnson & Johnson42Q3 20232.2%

View Argyle Capital Management Inc.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-04-29
13F-HR2024-02-05
13F-HR2023-10-26
13F-HR2023-07-27
13F-HR2023-04-27
13F-HR2023-02-06
13F-HR2022-10-21
13F-HR2022-07-20
13F-HR2022-04-27
13F-HR2022-01-25

View Argyle Capital Management Inc.'s complete filings history.

Compare quarters

Export Argyle Capital Management Inc.'s holdings